CNBX Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. CNBX Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 68% to $130,074. The net income raised on -$695,198 and profit margin reached -534%. Total operating expenses were $713,213.
Profit Margin
| 2015 | 0 | -541.38K | |
|---|---|---|---|
| 2016 | 112.5K | -307.18K | -273.05% |
| 2017 | 5.68K | -1.93M | -34022.54% |
| 2018 | 9.60K | -3.77M | -39335.66% |
| 2019 | 9.84K | 1.13M | 11510.41% |
| 2020 | 7.15K | -3.11M | -43490.25% |
| 2021 | 0 | -2.48M | |
| 2022 | 29.95K | -3.76M | -12581.02% |
| 2023 | 410.16K | -3.71M | -904.57% |
| 2024 | 130.07K | -695.19K | -534.46% |
CNBX Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 130.07K | 410.16K | 29.95K | 0 | 7.15K | 9.84K | 9.60K | 5.68K | 112.5K | 0 |
Cost of revenue | 0 | 0 | 198.52K | 220.92K | 0 | 0 | 1 | 7.01K | 0 | 0 |
Gross profit | 130.07K | 410.16K | -168.56K | -220.92K | 7.15K | 9.84K | 9.6K | -1.33K | 112.5K | 0 |
Operating exp. | ||||||||||
Research and development | 194.78K | 431.56K | 1.18M | 1.77M | 1.68M | 1.54M | 1.00M | 246.94K | 177.60K | 139.43K |
Selling and marketing | 0 | 15.97K | 15.97K | 20.24K | 59.99K | 288.16K | 422.01K | 287.45K | 960 | 62.71K |
Total operating expenses | 713.21K | 1.34M | 2.95M | 2.60M | 3.05M | 3.31M | 3.81M | 1.85M | 393.17K | 536.5K |
Operating income | -583.13K | -931.38K | -2.95M | -2.60M | -3.04M | -3.30M | -3.80M | -1.85M | -280.67K | -539.52K |
Other income (expenses), net | -112.05K | -2.77M | -769.28K | -594.27K | -4.42M | 4.43M | 32.11K | -79.94K | 674 | -1.86K |
Income before tax | -695.19K | -3.71M | -3.72M | -3.19M | -7.46M | 1.13M | -3.77M | -1.93M | -307.18K | -541.38K |
Income tax expense | 0 | 0 | 45.77K | -704.47K | -4.35M | 37.96K | 32.96K | 4.37K | 27.17K | 3.02K |
Net income | -695.19K | -3.71M | -3.76M | -2.48M | -3.11M | 1.13M | -3.77M | -1.93M | -307.18K | -541.38K |
Earnings per share | ||||||||||
Basic EPS | -0.02 | -0.42 | -3.08 | -2.16 | -2.78 | 1.03 | -3.76 | -2.1 | -0.36 | -0.65 |
Diluted EPS | -0.02 | -0.42 | -3.08 | -2.16 | -2.78 | 1.03 | -3.76 | -2.1 | -0.36 | -0.65 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |